Noncirrhotic Portal Fibrosis in Pediatric Population

被引:21
|
作者
Sood, Vikrant [1 ]
Lal, Bikrant B. [1 ]
Khanna, Rajeev [1 ]
Rawat, Dinesh [1 ]
Bihari, Chhagan [2 ]
Alam, Seema [1 ]
机构
[1] Inst Liver & Biliary Sci, Dept Pediat Hepatol, D-1, New Delhi 110070, India
[2] Inst Liver & Biliary Sci, Dept Pathol, New Delhi, India
关键词
noncirrhotic portal fibrosis; heptic venous pressure gradient; liver stiffness; CHRONIC LIVER-DISEASE; TRANSIENT ELASTOGRAPHY; HEPATOPULMONARY SYNDROME; HYPERTENSION; CHILDREN; MANAGEMENT; DIAGNOSIS; CIRRHOSIS; REEVALUATION; EXPERIENCE;
D O I
10.1097/MPG.0000000000001485
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Noncirrhotic portal fibrosis (NCPF) has been classically described as a disease of young to middle age with limited literature regarding its occurrence, onset, or clinical presentation in children. We hereby present a series of 19 patients diagnosed and managed as NCPF in pediatric age group. Methods: A retrospective review of all the patients presenting to the pediatric hepatology department (age < 18 years) and diagnosed as NCPF was done and data were evaluated. Results: A total of 19 patients were diagnosed as NCPF with median age at onset of symptoms and diagnosis as 10 years and 13.8 years respectively. Majority presented with left upper quadrant discomfort or mass. Laboratory parameters showed hypersplenism in majority with preserved liver synthetic functions. Median values for hepatic venous pressure gradient and liver stiffness measurement were 13.5 mmHg and 10.6 kPa, respectively. Classical hepatic histopathological features seen were maintained lobular architecture, atretic portal tracts, approximation of portal-portal and portal-central areas, and aberrant peripheral portal channels. During follow-up, majority of the patients did not show disease progression. Conclusions: NCPF is not an uncommon entity in pediatric population with age of onset in early second decade. Hepatic histopathology must be used to exclude cirrhosis and to confirm the diagnosis. Hepatic venous pressure gradient and liver stiffness measurement values, in some cases, may overlap with those in patients with cirrhosis and may not be diagnostic in isolation. Any patient presenting with evidence of portal hypertension with preserved hepatic functions, irrespective of the age, should be evaluated for possible NCPF.
引用
收藏
页码:748 / 753
页数:6
相关论文
共 50 条
  • [1] Noncirrhotic portal hypertension
    Da, Ben L.
    Koh, Christopher
    Heller, Theo
    CURRENT OPINION IN GASTROENTEROLOGY, 2018, 34 (03) : 140 - 145
  • [2] Histological analyses of trucut liver biopsies from patients with noncirrhotic portal fibrosis and extra-hepatic portal vein obstruction
    Vallonthaiel, Archana George
    Baloda, Vandana
    Singh, Lavleen
    Yadav, Rajni
    Kilambi, Ragini
    Battu, Sudha
    Sreenivas, Vishnubhatla
    Pal, Sujoy
    Acharya, Subrat K.
    DattaGupta, Siddhartha
    Shalimar
    Das, Prasenjit
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (05) : 127 - 135
  • [3] Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment
    Shiv Kumar Sarin
    Ashish Kumar
    Yogesh Kumar Chawla
    Sanjay Saran Baijal
    Radha Krishna Dhiman
    Wasim Jafri
    Laurentius A Lesmana
    Debendranath Guha Mazumder
    Masao Omata
    Huma Qureshi
    Rizvi Moattar Raza
    Peush Sahni
    Puja Sakhuja
    Mohammad Salih
    Amal Santra
    Barjesh Chander Sharma
    Praveen Sharma
    Gamal Shiha
    Jose Sollano
    Hepatology International, 2007, 1 : 398 - 413
  • [4] Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment
    Sarin, Shiv Kumar
    Kumar, Ashish
    Chawla, Yogesh Kumar
    Baijal, Sanjay Saran
    Dhiman, Radha Krishna
    Jafri, Wasim
    Lesmana, Laurentius A.
    Mazumder, Debendranath Guha
    Omata, Masao
    Qureshi, Huma
    Raza, Rizvi Moattar
    Sahni, Peush
    Sakhuja, Puja
    Salih, Mohammad
    Santra, Amal
    Sharma, Barjesh Chander
    Sharma, Praveen
    Shiha, Gamal
    Sollano, Jose
    HEPATOLOGY INTERNATIONAL, 2007, 1 (03) : 398 - 413
  • [5] IMMUNOLOGICAL PROFILE OF PATIENTS WITH NONCIRRHOTIC PORTAL FIBROSIS
    SARIN, SK
    NAYYAR, AK
    MALHOTRA, P
    SHARMA, BK
    KUMAR, R
    BROOR, SL
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1990, 5 (04) : 425 - 431
  • [6] Cirrhosis and Portal Hypertension in the Pediatric Population
    Chapin, Catherine A.
    Bass, Lee M.
    CLINICS IN LIVER DISEASE, 2018, 22 (04) : 735 - +
  • [7] Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
    Sahin, Abdurrahman
    Artas, Hakan
    Tunc, Nurettin
    Yalniz, Mehmet
    Bahcecioglu, Ibrahim Halil
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (08):
  • [8] Pathology of noncirrhotic portal hypertension: Clinicopathologic study in pediatric patients
    Abramowsky, C
    Romero, R
    Heffron, T
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2003, 6 (05) : 421 - 426
  • [9] Liver atrophy and regeneration in noncirrhotic portal vein thrombosis: Effect of surgical shunts
    Elnaggar, Abdulrhman S.
    Griesemer, Adam D.
    Bentley-Hibbert, Stuart
    Brown, Robert S., Jr.
    Martinez, Mercedes
    Lobritto, Steven J.
    Kato, Tomoaki
    Emond, Jean C.
    LIVER TRANSPLANTATION, 2018, 24 (07) : 881 - 887
  • [10] Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosis
    Spaander, M. C. W.
    van Buuren, H. R.
    Hansen, B. E.
    Janssen, H. L. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (04) : 529 - 534